The
orthopaedic sector is on the cusp of a transformative era, driven by
advancements in additive manufacturing, digital technology, and artificial
intelligence (AI), said Sushant Banerji, founder and CEO of Orthotech.
He stated, "The next decade will be defined by
personalized, technology-driven solutions. Additive manufacturing and digital
technology, combined with AI, will revolutionize orthopaedics, dentistry, and
even pharmaceuticals." Emerging trends include the adoption of 3D printing
for pre-operative planning and customized implants, augmented and virtual
reality (AR/VR) for surgical precision, and a focus on sustainable implant
materials.”
Founded
in 1998, Orthotech set out with a vision to provide world-class orthopaedic
implants and instruments at affordable prices. Initially focusing on hip
replacement products, Orthotech collaborated with the Central Glass and Ceramic
Research Institute (CGCRI) to pioneer plasma coating technology, delivering
India’s first hydroxyapatite-coated implants. This breakthrough challenged
multinational dominance and set a new benchmark in quality and affordability.
Expanding its horizons, Orthotech became the first
Indian company in the orthopaedic industry to embrace 3D printing technology.
Partnerships with prestigious institutions like IIT Guwahati and IISc Bangalore
have allowed the company to continuously innovate and offer tailored solutions
for joint implants and beyond.
Orthotech’s path to leadership has not been without challenges.
The market’s unorganized players, who often disregard regulatory norms, create
pricing disruptions and raise concerns over unsafe practices. Additionally, a
preference for imported products persists despite India’s advancements in
quality and technology.
"We address these challenges by educating
surgeons and demonstrating our compliance with global standards through
facility visits. This strategy has helped build trust in Orthotech’s locally
made, high-quality solutions," Banerji explained.
Orthotech is poised for significant growth, with plans
to expand both domestically and internationally. To penetrate new markets, the
company is pursuing certifications such as MDSAP, which will facilitate access
to untapped regions.
On the innovation front, Orthotech is a pioneer in 3D
printed, patient-specific implants, offering anatomically precise solutions for
hips, shoulders, knees, and more. Upcoming launches include ceramic implants
and expansions in the joint replacement systems portfolio. The company is also
exploring new materials through additive manufacturing and venturing into
maxillofacial and onco-orthopaedic solutions.
Orthotech distinguishes itself through continuous
innovation and strategic collaborations with leading research institutions.
"Our pioneering technologies, such as robotic plasma coating and 3D metal
printing, set us apart from competitors," Banerji stated.
By fostering transparency and delivering quality,
Orthotech has solidified its reputation as a trusted partner for surgeons and
patients alike.
The shift toward patient-specific implants has been a
game-changer. Utilizing 3D CT scanning and additive manufacturing, Orthotech
designs implants tailored to each patient’s anatomy. This approach not only
ensures a precise fit but also reduces surgery time and accelerates recovery.
Collaborations with IIT Guwahati and IISc Bangalore have been instrumental in
adapting these technologies to meet national and international standards.
By optimizing production processes and leveraging cutting-edge
technologies, the company offers advanced implants at reasonable prices.
"This balance ensures that patients worldwide can benefit from
high-quality orthopaedic care," Banerji emphasized.
Orthotech
adheres to stringent quality assurance frameworks, meeting both national and
international medical standards. Investments in certifications such as MDSAP
and collaborations with premier institutions reinforce the company’s commitment
to excellence. Regular audits and ethical manufacturing practices ensure that
Orthotech remains a trusted name in the orthopaedic industry.
(Source- Pharmabiz)
3 comments:
This is interesting !!
This is very insightful
Post a Comment